NCT07157202Not yet recruiting
Associating Gastric Infection With Autoimmune Flare Severity in an Egyptians
Association Between Helicobacter Pylori Infection and Disease Activity in Patients With Systemic Lupus Erythematosus (SLE)
Source: ClinicalTrials.gov · Last updated 5 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
A cross-sectional, observational study aims to evaluate the relationship between Helicobacter pylori infection and disease activity in patients diagnosed with systemic lupus erythematosus (SLE), using a combination of structured patient interviews, standardized disease assessments, and laboratory detection of H. pylori by stool antigen testing .
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 115 (estimated)
- First submitted
- 28 Aug 2025
- Start date
- 30 Aug 2026
- Primary completion date
- 30 Oct 2027
- Lead sponsor
- Assiut University
- Diseases
- Lupus (SLE)
- NCT number
- NCT07157202
What you commit to
- Study type: Observational
- Planned participants: 115
- From 30 Aug 2026 to the primary completion date, 30 Oct 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with a history of gastric surgery or known gastrointestinal malignancy.
- Patients currently receiving immunosuppressive therapy for conditions other than SLE.
- Patients with coexisting autoimmune diseases other than SLE.
- Pregnant or lactating women.
- Patients with active infections (other than H. pylori) at the time of enrollment.
Who the study is looking for
- Adult patients (aged ≥18 years) with a confirmed diagnosis of SLE according to the American College of Rheumatology (ACR) or Systemic Lupus International Collaborating Clinics (SLICC) classification criteria.
- Patients who provide written informed consent to participate in the study. Patients who have not received antibiotics or proton pump inhibitors (PPIs) in the four weeks
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.